• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Lobectomy versus sub-lobar resection in patients with stage IA right middle lobe non-small cell lung cancer: a propensity score matched analysis.IA期右中叶非小细胞肺癌患者肺叶切除术与肺段切除术的倾向评分匹配分析
J Thorac Dis. 2019 Jun;11(6):2523-2534. doi: 10.21037/jtd.2019.05.48.
2
Effects of Lobectomy versus Sub-Lobar Resection on the Survival in Adults with Stage IA Left Upper Lobe Non-Small Cell Lung Cancer: A Retrospective Cohort Study Based on the Surveillance, Epidemiology, and End Results Database.左肺上叶ⅠA 期非小细胞肺癌行肺叶切除术与亚肺叶切除术对患者生存的影响:基于监测、流行病学和最终结果数据库的回顾性队列研究。
Oncology. 2024;102(6):525-532. doi: 10.1159/000534195. Epub 2023 Oct 9.
3
Comparison of Lobectomy and Sublobar Resection for Stage IA Elderly NSCLC Patients (≥70 Years): A Population-Based Propensity Score Matching's Study.IA期老年非小细胞肺癌患者(≥70岁)肺叶切除术与肺段切除术的比较:一项基于人群的倾向评分匹配研究。
Front Oncol. 2021 May 7;11:610638. doi: 10.3389/fonc.2021.610638. eCollection 2021.
4
Prognostic Significance of Lymph Node Count Removed at Sublobar Resection in Pathologic Stage IA Non-Small-cell Lung Cancer: A Population-Based Analysis.亚肺叶切除治疗ⅠA 期非小细胞肺癌时淋巴结清扫数目对预后的影响:基于人群的分析。
Clin Lung Cancer. 2021 Jul;22(4):e563-e573. doi: 10.1016/j.cllc.2020.09.015. Epub 2020 Oct 14.
5
Surgery for advanced-stage non-small cell lung cancer: lobectomy or sub-lobar resection?晚期非小细胞肺癌的手术治疗:肺叶切除术还是肺段以下切除术?
Transl Lung Cancer Res. 2021 Mar;10(3):1408-1423. doi: 10.21037/tlcr-21-39.
6
Survival rates after lobectomy versus sublobar resection for early-stage right middle lobe non-small cell lung cancer.右中叶早期非小细胞肺癌行肺叶切除术与亚肺叶切除术的生存率。
Thorac Cancer. 2018 Aug;9(8):1026-1031. doi: 10.1111/1759-7714.12782. Epub 2018 Jun 21.
7
Sublobar resection for node-negative lung cancer 2-5 cm in size.2-5cm 大小的淋巴结阴性肺癌行亚肺叶切除术。
Eur J Cardiothorac Surg. 2019 Nov 1;56(5):858-866. doi: 10.1093/ejcts/ezz146.
8
Survival After Lobectomy vs. Sublobar Resection for Stage IA Large-Cell Neuroendocrine Carcinoma of the Lung: A Population-Based Study.肺IA期大细胞神经内分泌癌肺叶切除与肺段切除术后的生存率:一项基于人群的研究。
Front Surg. 2022 Mar 15;9:856048. doi: 10.3389/fsurg.2022.856048. eCollection 2022.
9
Selection of the surgical approach for patients with cStage IA lung squamous cell carcinoma: A population-based propensity score matching analysis.cStage IA期肺鳞状细胞癌患者手术入路的选择:一项基于人群的倾向评分匹配分析。
Front Oncol. 2022 Aug 23;12:946800. doi: 10.3389/fonc.2022.946800. eCollection 2022.
10
Sublobar resection is equivalent to lobectomy for clinical stage 1A lung cancer in solid nodules.亚肺叶切除术与肺叶切除术在实性结节临床Ⅰ A 期肺癌中的疗效相当。
J Thorac Cardiovasc Surg. 2014 Feb;147(2):754-62; Discussion 762-4. doi: 10.1016/j.jtcvs.2013.09.065. Epub 2013 Nov 23.

引用本文的文献

1
Middle lobe tumors and lymphovascular invasion as independent predictors of recurrence-free survival in stage I NSCLC.中叶肿瘤和脉管侵犯作为Ⅰ期非小细胞肺癌无复发生存的独立预测因素。
BMC Pulm Med. 2025 Feb 26;25(1):93. doi: 10.1186/s12890-025-03560-w.
2
Right apical-posterior segmentectomy with abnormal anterior segmental bronchus and artery: a case report.右肺尖段后段切除术伴异常前段支气管和动脉:一例报告。
J Cardiothorac Surg. 2021 Jul 6;16(1):189. doi: 10.1186/s13019-021-01570-3.
3
Sublobectomy versus lobectomy for long-term survival outcomes of early-stage non-small cell lung cancer with a tumor size ≤2 cm accompanied by visceral pleural invasion: a SEER population-based study.肺段切除术与肺叶切除术治疗肿瘤大小≤2 cm且伴有脏层胸膜侵犯的早期非小细胞肺癌的长期生存结局:一项基于监测、流行病学和最终结果(SEER)数据库人群的研究
J Thorac Dis. 2020 Mar;12(3):592-604. doi: 10.21037/jtd.2019.12.121.

本文引用的文献

1
Survival rates after lobectomy versus sublobar resection for early-stage right middle lobe non-small cell lung cancer.右中叶早期非小细胞肺癌行肺叶切除术与亚肺叶切除术的生存率。
Thorac Cancer. 2018 Aug;9(8):1026-1031. doi: 10.1111/1759-7714.12782. Epub 2018 Jun 21.
2
Reassessment of Right Middle Lobe Lung Cancer: Comparison of Segments 4 and 5 Tumors.右中叶肺癌再评估:段 4 和段 5 肿瘤的比较。
Ann Thorac Surg. 2018 May;105(5):1543-1550. doi: 10.1016/j.athoracsur.2017.12.007. Epub 2018 Jan 9.
3
Long-term outcomes of stage I NSCLC (≤3 cm) patients following segmentectomy are equivalent to lobectomy under analogous extent of lymph node removal: a PSM based analysis.I期非小细胞肺癌(≤3cm)患者在进行类似范围淋巴结清扫的肺段切除术后的长期预后与肺叶切除术相当:一项基于倾向评分匹配的分析。
J Thorac Dis. 2017 Nov;9(11):4561-4573. doi: 10.21037/jtd.2017.10.129.
4
Analysis of variation in bronchovascular pattern of the right middle and lower lobes of the lung using three-dimensional CT angiography and bronchography.使用三维CT血管造影和支气管造影分析右肺中叶和下叶支气管血管模式的变异
Gen Thorac Cardiovasc Surg. 2017 Jun;65(6):343-349. doi: 10.1007/s11748-017-0754-4. Epub 2017 Feb 14.
5
The importance of lymph node dissection accompanying wedge resection for clinical stage IA lung cancer.对于临床IA期肺癌,楔形切除术中进行淋巴结清扫的重要性。
Eur J Cardiothorac Surg. 2017 Mar 1;51(3):511-517. doi: 10.1093/ejcts/ezw343.
6
Sublobectomy versus lobectomy for stage I non-small cell lung cancer in the elderly.肺段切除术与肺叶切除术治疗老年Ⅰ期非小细胞肺癌。
Int J Surg. 2017 Jan;37:1-7. doi: 10.1016/j.ijsu.2016.11.090. Epub 2016 Nov 24.
7
A Matched Comparison Study of Uniportal Versus Triportal Thoracoscopic Lobectomy and Sublobectomy for Early-stage Nonsmall Cell Lung Cancer.单孔与三孔胸腔镜肺叶切除术及亚肺叶切除术治疗早期非小细胞肺癌的配对比较研究
Chin Med J (Engl). 2015 Oct 20;128(20):2731-5. doi: 10.4103/0366-6999.167298.
8
Pulmonary middle lobectomy for non-small-cell lung cancer: effectiveness and prognostic implications.非小细胞肺癌的肺中叶切除术:有效性及预后意义
Eur J Cardiothorac Surg. 2015 Dec;48(6):e117-23. doi: 10.1093/ejcts/ezv314. Epub 2015 Sep 15.
9
Sublobectomy versus lobectomy for stage IA (T1a) non-small-cell lung cancer: a meta-analysis study.肺段切除术与肺叶切除术治疗IA期(T1a)非小细胞肺癌的Meta分析研究
World J Surg Oncol. 2014 May 1;12:138. doi: 10.1186/1477-7819-12-138.
10
Adjuvant treatment for elderly patients with early-stage lung cancer treated with limited resection.局限性切除治疗的老年早期肺癌患者的辅助治疗。
Ann Am Thorac Soc. 2013 Dec;10(6):622-8. doi: 10.1513/AnnalsATS.201305-127OC.

IA期右中叶非小细胞肺癌患者肺叶切除术与肺段切除术的倾向评分匹配分析

Lobectomy versus sub-lobar resection in patients with stage IA right middle lobe non-small cell lung cancer: a propensity score matched analysis.

作者信息

Lin Gang, Liu Haibo, Li Jian

机构信息

Department of Thoracic Surgery, Peking University First Affiliated Hospital, Peking University, Beijing 100034, China.

出版信息

J Thorac Dis. 2019 Jun;11(6):2523-2534. doi: 10.21037/jtd.2019.05.48.

DOI:10.21037/jtd.2019.05.48
PMID:31372289
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6626808/
Abstract

BACKGROUND

The aim of the present study was to compare the prognostic outcomes of patients with stage IA right middle lobe non-small cell lung cancers (RML NSCLCs) that underwent either lobectomy (LR) or sub-lobar resection (SLR) after 1:1 propensity score matching (PSM).

METHODS

Patients with stage IA RML NSCLC were identified from the Surveillance, Epidemiology and End Results (SEER) database from 2005 to 2015. Cox regression analysis was carried out to compare lung cancer specific survival (LCSS) following LR or SLR before and after PSM. Subgroup analysis of LCSS stratified by tumor size (≤1, 1-2, and 2-3 cm) was also performed.

RESULTS

A total of 1,104 patients met the inclusion criteria. One hundred ninety-eight (17.9%) patients underwent SLR, and 906 (82.1%) underwent LR. There were significant differences between patients of LR and SLR groups with regard to the tumor size and the number of examined lymph nodes. After PSM, 147 matched pairs (n=294) were selected. Multivariable cox regression analysis revealed no difference in the LCSS of patients that underwent either LR or SLR before [hazard ratio (HR): 0.881, 95% CI: 0.547-1.422, P=0.605] and after PSM (HR: 0.778, 95% CI: 0.409-1.480, P=0.444). Subgroup analysis revealed no significant difference in LCSS between patients of LR and SLR groups with regard to the tumor size (all P>0.05).

CONCLUSIONS

Similar to lymphadenectomy, the prognostic outcomes in patients with stage IA RML NSCLC were comparable between LR and SLR.

摘要

背景

本研究旨在比较1:1倾向评分匹配(PSM)后接受肺叶切除术(LR)或肺叶下切除术(SLR)的IA期右中叶非小细胞肺癌(RML NSCLC)患者的预后结果。

方法

从2005年至2015年的监测、流行病学和最终结果(SEER)数据库中识别出IA期RML NSCLC患者。进行Cox回归分析以比较PSM前后接受LR或SLR后的肺癌特异性生存(LCSS)。还对按肿瘤大小(≤1、1-2和2-3 cm)分层的LCSS进行了亚组分析。

结果

共有1104例患者符合纳入标准。198例(17.9%)患者接受了SLR,906例(82.1%)接受了LR。LR组和SLR组患者在肿瘤大小和检查淋巴结数量方面存在显著差异。PSM后,选择了147对匹配对(n = 294)。多变量Cox回归分析显示,PSM前后接受LR或SLR的患者的LCSS没有差异[风险比(HR):0.881,95%置信区间(CI):0.547-1.422,P = 0.605]以及PSM后(HR:0.778,95% CI:0.409-1.480,P = 0.444)。亚组分析显示,LR组和SLR组患者在肿瘤大小方面的LCSS没有显著差异(所有P>0.05)。

结论

与淋巴结清扫术相似,IA期RML NSCLC患者接受LR和SLR后的预后结果相当。